Valsartan Clinical Trials

• A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
  ClinicalTrials.gov Identifier: NCT00171119 - Active, not recruiting
  Hypertension; Diabetic Nephropathy
  
• A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-Term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
  ClinicalTrials.gov Identifier: NCT00386607 - Active, not recruiting
  Hypertension
  
• Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00190580 - Recruiting
  Chronic Kidney Disease; Hypertension
  
• A Morbi-Mortality and Remodeling Study with Valsartan
  ClinicalTrials.gov Identifier: NCT00133328 - Active, not recruiting
  Hypertension; Ischemic Heart Disease; Congestive Heart Failure
  
• Valsartan in Cardiovascular Disease with Renal Dysfunction (The V-CARD) Study
  ClinicalTrials.gov Identifier: NCT00140790 - Recruiting
  Hypertension; Renal Dysfunction
  
• Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00426478 - Active, not recruiting
  Hypertension
  
• Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin
  ClinicalTrials.gov Identifier: NCT00385931 - Completed
  Hypertension; Hypercholesterolemia; Dyslipidemia
  
• Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
  ClinicalTrials.gov Identifier: NCT00170989 - Completed
  Hypertension
  
• Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone
  ClinicalTrials.gov Identifier: NCT00170963 - Completed
  Hypertension
  
• Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)
  ClinicalTrials.gov Identifier: NCT00149227 - Recruiting
  Hypertension; Ischemic Heart Disease; Congestive Heart Failure; Stroke
  
• A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure
  ClinicalTrials.gov Identifier: NCT00171353 - Active, not recruiting
  Hypertension
  
• Safety and Efficacy of Valsartan Versus Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00396656 - Active, not recruiting
  Hypertension
  
• Comparison of Valsartan with Amlodipine in Hypertensive Patients with Glucose Intolerance
  ClinicalTrials.gov Identifier: NCT00129233 - Recruiting
  Hypertension; Type 2 Diabetes Mellitus; Impaired Glucose Tolerance
  
• Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
  ClinicalTrials.gov Identifier: NCT00171054 - Active, not recruiting
  Hypertension
  
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00277472 - Active, not recruiting
  Hypertension
  
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00280540 - Active, not recruiting
  Hypertension
  
• Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
  ClinicalTrials.gov Identifier: NCT00400777 - Active, not recruiting
  Hypertension
  
• Efficacy and Safety of Valsartan and Amlodipine in Adults With Moderate, Inadequately Controlled Hypertension
  ClinicalTrials.gov Identifier: NCT00523744 - Active, not recruiting
  Hypertension
  
• Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
  ClinicalTrials.gov Identifier: NCT00439738 - Active, not recruiting
  Hypertension
  
• Safety and Efficacy of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS
  ClinicalTrials.gov Identifier: NCT00308425 - Active, not recruiting
  De Novo Renal Transplantation
  
• A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients
  ClinicalTrials.gov Identifier: NCT00219102 - Active, not recruiting
  Hypertension; Diabetes
  
• Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)
  ClinicalTrials.gov Identifier: NCT00154271 - Completed
  Hypertension
  
• GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence
  ClinicalTrials.gov Identifier: NCT00376272 - Active, not recruiting
  Atrial Fibrillation
  
• Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
  ClinicalTrials.gov Identifier: NCT00446524 - Active, not recruiting
  Hypertension
  
• Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure
  ClinicalTrials.gov Identifier: NCT00171106 - Active, not recruiting
  Diastolic Dysfunction, Symptomatic Heart Failure
  
• To Compare the Efficacy and Safety of TW vs Valsartan in the MN
  ClinicalTrials.gov Identifier: NCT00518219 - Recruiting
  Membranous Nephropathy
  
• To Compare the Efficacy and Safety of TW vs Valsartan in the DN
  ClinicalTrials.gov Identifier: NCT00518362 - Recruiting
  Diabetic Nephropathy
  
• Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
  ClinicalTrials.gov Identifier: NCT00425997 - Active, not recruiting
  Hypertension
  
• Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00413049 - Active, not recruiting
  Hypertension
  
• Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00413413 - Active, not recruiting
  Hypertension
  
• Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study
  ClinicalTrials.gov Identifier: NCT00460213 - Recruiting
  Hypertension
  
• A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00171093 - Active, not recruiting
  Hypertension; Hypercholesterolemia
  
• Open Label Extension Study to Evaluate the Long Term Use of Valsartan in 1-5 Year Old Hypertensive Children
  ClinicalTrials.gov Identifier: NCT00457626 - Recruiting
  Hypertension
  
• Safety and Efficacy of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00437645 - Active, not recruiting
  Essential Hypertension
  
• Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
  ClinicalTrials.gov Identifier: NCT00351130 - Active, not recruiting
  Hypertension
  
• A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00170937 - Active, not recruiting
  Metabolic Syndrome; Hypertension; Pre-Hypertension
  
• Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
  ClinicalTrials.gov Identifier: NCT00446563 - Active, not recruiting
  Hypertension; Hypertrophy, Left Ventricular
  
• A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
  ClinicalTrials.gov Identifier: NCT00426348 - Recruiting
  Glomerulonephritis, IGA
  
• Long Term Safety, Tolerability and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension
  ClinicalTrials.gov Identifier: NCT00446511 - Recruiting
  Hypertension
  
• Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00548067 - Recruiting
  Hypertension
  
• A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00294086 - Active, not recruiting
  Chronic Heart Failure
  
• To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00550095 - Recruiting
  Microalbuminuria; Proteinuria
  
• Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months
  ClinicalTrials.gov Identifier: NCT00487123 - Recruiting
  Hypertension
  
• A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg
  ClinicalTrials.gov Identifier: NCT00241137 - Completed
  Hypertension
  
• Telmisartan vs. valsartan missed dose
  ClinicalTrials.gov Identifier: NCT00034840 - Completed
  Hypertension
  
• To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00415883 - Completed
  Healthy
  
• Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure
  ClinicalTrials.gov Identifier: NCT00433836 - Recruiting
  Hypertension
  
• Dose Response of Valsartan on Sitting Systolic Blood Pressure in 1-5 Year Old Children With High Blood Pressure
  ClinicalTrials.gov Identifier: NCT00435162 - Recruiting
  Hypertension
  
• Prevention of CHOP-Induced Chronic Cardiotoxicity
  ClinicalTrials.gov Identifier: NCT00162955 - Recruiting
  Non-Hodgkin''s Lymphoma
  
• Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00500604 - Recruiting
  Hypertension
  
• Long-term Study of Starlix+Diovan to Delay Type II Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00097786 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Effect of Valsartan on Carotid Artery Disease
  ClinicalTrials.gov Identifier: NCT00208767 - Recruiting
  Carotid Artery Diseases; Atherosclerosis
  
• Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00425373 - Recruiting
  Essential Hypertension
  
• Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome
  ClinicalTrials.gov Identifier: NCT00409578 - Recruiting
  Post Acute Coronary Syndrome; Myocardial Ischemia
  
• The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction
  ClinicalTrials.gov Identifier: NCT00523549 - Recruiting
  Hypertension; Diastolic Dysfunction
  
• Valsartan in Elderly Isolated Systolic Hypertension (VALISH) Study
  ClinicalTrials.gov Identifier: NCT00151229 - Active, not recruiting
  Elderly; Isolated Systolic Hypertension
  
• Effectiveness of Losartan 50 mg/HCTZ 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Hypertension Not Controlled on Monotherapy
  ClinicalTrials.gov Identifier: NCT00546754 - Recruiting
  Hypertension
  
• Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS Patients
  ClinicalTrials.gov Identifier: NCT00409487 - Not yet recruiting
  Hypertension,; Obstructive Sleep Apnea
  
• A Prospective, Randomised, Double-Blind, Double-Dummy, Forced-Titration, Multicentre, Parallel Group, One Year Treatment Trial to Investigate the Efficacy of Telmisartan 80 Mg Versus Valsartan 160 Mg in Hypertensive Type 2 Diabetic Patients with Overt Nep
  ClinicalTrials.gov Identifier: NCT00153023 - Completed
  Diabetic Nephropathies; Hypertension
  
• Antiproteinuric Effect of Valsartan and Lisinopril
  ClinicalTrials.gov Identifier: NCT00171574 - Completed
  Hypertension; Diabetic Nephropathy
  
• VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria
  ClinicalTrials.gov Identifier: NCT00171067 - Completed
  Hypertension
  
• Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose
  ClinicalTrials.gov Identifier: NCT00302705 - Completed
  Hypertension
  
• A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00392262 - Completed
  Hypertension
  
• Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00409643 - Completed
  Hypertension
  
• A Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Phase IV Study Comparing Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg [Micardis HCT] Versus Valsartan 160 Mg + Hydrochlorothiazide 25 Mg [Diovan HCT] Taken Orally for Eight Weeks in Patien
  ClinicalTrials.gov Identifier: NCT00168779 - Completed
  Hypertension
  
• Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes
  ClinicalTrials.gov Identifier: NCT00241124 - Completed
  Hypertension
  
• VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil
  ClinicalTrials.gov Identifier: NCT00171015 - Completed
  Hypertension
  
• A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy
  ClinicalTrials.gov Identifier: NCT00327145 - Completed
  Hypertension
  
• VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00171132 - Completed
  Hypertension
  
• Study to Compare the Effect of Valsartan vs Atenolol on Pro-Thrombotic State in Hypertensive Patients.
  ClinicalTrials.gov Identifier: NCT00171756 - Completed
  Hypertension
  
• VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00394823 - Completed
  Hypertension
  
• Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
  ClinicalTrials.gov Identifier: NCT00171535 - Completed
  Hypertension
  
• Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
  ClinicalTrials.gov Identifier: NCT00171561 - Completed
  Hypertension
  
• Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.
  ClinicalTrials.gov Identifier: NCT00409760 - Completed
  Hypertension
  
• Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone
  ClinicalTrials.gov Identifier: NCT00171002 - Completed
  Hypertension
  
• One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00409851 - Completed
  Hypertension
  
• Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.
  ClinicalTrials.gov Identifier: NCT00416468 - Completed
  Healthy
  
• Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.
  ClinicalTrials.gov Identifier: NCT00416728 - Completed
  Healthy
  
• A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00241007 - Completed
  Hypertension
  
• Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension
  ClinicalTrials.gov Identifier: NCT00273299 - Completed
  Hypertension
  
• Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction
  ClinicalTrials.gov Identifier: NCT00171327 - Completed
  Hypertension; Dyslipidemia
  
• A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age
  ClinicalTrials.gov Identifier: NCT00171041 - Completed
  Hypertension
  
• The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00185055 - Completed
  Healthy
  
• 8-Week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension
  ClinicalTrials.gov Identifier: NCT00327587 - Completed
  Hypertension
  
• Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine
  ClinicalTrials.gov Identifier: NCT00367939 - Completed
  Hypertension
  
• A Randomized, Double-Blind, Placebo Controlled Comparison of Telmisartan HCT and Valsartan HCT in HTN Stage I/II Patient
  ClinicalTrials.gov Identifier: NCT00240448 - Completed
  Hypertension
  
• Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood Pressure
  ClinicalTrials.gov Identifier: NCT00219180 - Completed
  Hypertension
  
• A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 – 5 Years Who Have Hypertension
  ClinicalTrials.gov Identifier: NCT00171028 - Completed
  Hypertension
  
• VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-Term Hemodialysis
  ClinicalTrials.gov Identifier: NCT00171080 - Completed
  Hypertension
  
• A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00170976 - Completed
  Hypertension
  
• The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure
  ClinicalTrials.gov Identifier: NCT00241098 - Completed
  Hypertension; Congestive Heart Failure
  
• Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00394745 - Completed
  Hypertension; Metabolic Syndrome
  
• A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients
  ClinicalTrials.gov Identifier: NCT00219193 - Completed
  Hypertension.
  
• Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension
  ClinicalTrials.gov Identifier: NCT00350168 - Completed
  Hypertension
  
• Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
  ClinicalTrials.gov Identifier: NCT00353912 - Completed
  Hypertension
  
• Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide
  ClinicalTrials.gov Identifier: NCT00360178 - Completed
  Hypertension
  
• Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00241150 - Completed
  Hypertension; Metabolic Syndrome
  
• Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension
  ClinicalTrials.gov Identifier: NCT00333489 - Completed
  Hypertension
  
• Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance
  ClinicalTrials.gov Identifier: NCT00241072 - Completed
  Hypertension; Impaired Glucose Tolerance
  
• A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00254475 - Completed
  Essential Hypertension; Hypercholesterolemia